| Sat, Dec 12, 2009 | | • | [$$] Research Reports
at Barrons.com (Sat, Dec 12)
| | Thu, Dec 10, 2009 | | • | CytRx to Discuss Recent Progress at the Lippert/Heilshorn & Associates Life Sciences Virtual Conference
Business Wire (Thu, Dec 10)
| | Mon, Dec 7, 2009 | | • | UPDATE - CytRx says prelim results of cancer drug shows promise
at Reuters (Mon, Dec 7)
| | • | CytRx Announces Positive Phase 2 Results For Tamibarotene in the Treatment of Relapsed Acute Promyelocytic Leukemia
Business Wire (Mon, Dec 7)
| | Fri, Dec 4, 2009 | | • | CYTRX CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
EDGAR Online (Fri, Dec 4)
| | Thu, Dec 3, 2009 | | • | Behind the Business: 3 Questions for Vical
at Motley Fool (Thu, Dec 3)
| | • | SeaChange, Tenet: Early Volume Plays
at TheStreet.com (Thu, Dec 3)
| | • | CytRx Corporation: A Solid Rebound Play?
at Seeking Alpha (Thu, Dec 3)
| | • | Coverage initiated on CytRx by Merriman
Briefing.com (Thu, Dec 3)
| | Wed, Dec 2, 2009 | | • | CytRx Corporation (NASDAQ: CYTR) Looking More Like a Solid Rebound Play
Marketwire (Wed, Dec 2)
| | • | CytRx: FDA lifts 2-year hold on arimoclomol tests
AP (Wed, Dec 2)
| | • | UPDATE - CytRx says FDA lifts clinical hold on Lou Gehrig's drug
at Reuters (Wed, Dec 2)
| | • | CytRx Announces That FDA Lifts Clinical Hold of Arimoclomol in ALS
Business Wire (Wed, Dec 2)
| | Tue, Dec 1, 2009 | | • | CYTRX CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
EDGAR Online (Tue, Dec 1)
| | • | CytRx Expands Management Team and Broadens Oncology Franchise
Business Wire (Tue, Dec 1)
| | Thu, Nov 26, 2009 | | • | CytRx Announces First of Two Positive Developments Ahead
at Seeking Alpha (Thu, Nov 26)
| | Tue, Nov 24, 2009 | | • | CytRx Announces Plan to Initiate a Phase 2 Clinical Trial with INNO-206 in Patients with Advanced Soft Tissue Sarcomas
Business Wire (Tue, Nov 24)
| | • | CytRx Corporation: Key Developments Ahead
at Seeking Alpha (Tue, Nov 24)
| | Mon, Nov 23, 2009 | | • | Pending Key Developments Ahead for CytRx Corporation (NASDAQ: CYTR)
Marketwire (Mon, Nov 23)
| | • | CytRx: Technical Breakout Imminent
at Seeking Alpha (Mon, Nov 23)
|
Add CYTR News to My Yahoo!:
 
| |
|
0.26% Nasdaq 0.00%
Headlines
